Harfst & Associates’s Chemours CC Stock Holding History

Harfst & Associates’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-184	Closed	-$6K	–	101
2017 Q2	$6K	Hold	184	–	–	﹤0.01%	202
2017 Q1	$7K	Buy	+184	New	+$5.54K	﹤0.01%	241

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Harfst & Associates's CC Position: Q3 2017 in Review

Harfst & Associates sold out of Chemours (CC) in Q3 2017, closing a stake of 184 shares — an estimated $6K sold.

Harfst & Associates first reported a position in CC in Q1 2017 and held it in 2 quarters. The position peaked at $7K in Q1 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

Harfst & Associates reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
Harfst & Associates sold 184 Chemours shares in Q3 2017, an estimated $6K.
Harfst & Associates first reported a position in Chemours in Q1 2017 and held it in 2 quarters.
Harfst & Associates's Chemours position peaked at $7K in Q1 2017.
499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on Harfst & Associates's 13F filing for Q3 2017, filed 7 Nov 2017.